Flagship explainer
What drives Evolent Health, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$535M | FY2025 |
| |
| Income before tax | −$535M | FY2025 |
|
| Operating income | −$410M | FY2025 |
|
| $1.9B | FY2025 |
| |
| Ending assets | $1.9B | FY2025 |
|
| Beginning assets | $2.5B | FY2024 |
|
| $415M | FY2025 |
| |
| $1.0B | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001628908-25-000020
- SEC filingFiling detailsAccession 0001628908-26-000015